Search for: "Eli Lilly "
Results 1841 - 1860
of 2,131
Sorted by Relevance
|
Sort by Date
1 Mar 2017, 6:38 am
Referring to its own decision in Actavis v Eli Lilly ([2015] EWCA Civ 555; [2015] Bus LR 1068), the Court took this opportunity to comment on the impossible burden that reliance on prosecution history places on the skilled reader if it were to be recognised as a legitimate aid to construction. [read post]
20 Apr 2017, 9:30 pm
” Although some it expect it to be a blockbuster treatment for rheumatoid arthritis, baricitinib — Eli Lilly’s new oral medication to treat rheumatoid arthritis—was not approved by the U.S. [read post]
13 Jun 2012, 7:24 am
Second, with that her measly $6.2 million, she wouldn’t even come close to cracking the top ten salaries of CEOs in the pharmaceutical industry: Bill Weldon – J&J - $28.7M Daniel Vasella - Novartis – $27M Miles White – Abbott- $25.6M Jeffrey Kindler – Pfizer- $24.7M Richard Clark – Merck – $24.6M Robert Coury – Mylan – $22.9M Kevin Sharer – Amgen – $21.1M James Mullen – Biogen Idec – $20M John… [read post]
11 Mar 2016, 6:02 am
, Day 24: Missing Balance on IP Border Measures, Day 25: The Treaties With the Treaty, Day 26: Why It Limits Canadian Cultural Policies, Day 27: Source Code Disclosure Confusion, Day 28: Privacy Risks from Source Code Rules, Day 29: Cultural Policy Innovation Uncertainty, Day 30: Losing Our Way on Geographical Indications, Day 31: Canadian Trademark Law Overhaul, Day 32: Illusory Safeguards Against Encryption Backdoors, Day 33: Setting the Rules for a Future Pharmacare Program, Day 34: PMO Was… [read post]
3 Apr 2023, 9:05 pm
Their rank-ordered, top 20 holdings are Microsoft, Apple, Alphabet (Google), Amazon, Tesla, UnitedHealth, Nvidia, Visa, Johnson & Johnson, JPMorgan Chase, Lilly Eli, Mastercard, Facebook (now Meta), Berkshire Hathaway, ExxonMobil, Danaher, Bank of America, Thermo Fisher Scientific, Adobe Systems, and Broadcom. [read post]
20 Aug 2010, 4:25 am
Eli Lilly & Co., 101 F.3d 1196, 1202 (7th Cir. 1996); Class Plaintiffs v. [read post]
12 Jan 2017, 8:22 am
January, March 2018 – Two bellwether cases involving Axiron, which is manufactured by Eli Lilly and Company, will go to trial. [read post]
30 Nov 2021, 9:36 am
Eli Lilly & Co., 598 F.3d 1336 (Fed. [read post]
12 Jun 2017, 6:00 am
Eli Lilly & Co v Actavis UK Ltd & Ors, heard 4-6 Apr 2017. [read post]
24 Oct 2011, 9:36 am
Eli Lilly and Co., No. 2008-1248 (Fed. [read post]
8 Oct 2019, 9:44 am
”) Eli Lilly and Company v. [read post]
27 Aug 2012, 1:31 pm
Eli Lilly & Co, 99 F.R.D. 126, 128 (D.D.C. 1983)).Similarly, the court addressed the notion that a treater serving as an expert witness for the defense would somehow violate a fiduciary duty to her patient/plaintiff, a duty that supposedly involved assisting the plaintiff in litigation. [read post]
6 Oct 2017, 2:34 pm
Eli Lilly, the court reaffirmed that written description is determined based on the state of the art as of a patent’s priority date and that evidence which illuminates the state of the art only subsequent to the priority date is not relevant to written description. [read post]
20 May 2009, 5:18 am
BIO Policy Briefing raises the IP social media question (PatentlyBIOtech) Vietnam: Patentability of medical use claims in Vietnam (RelatIP) Products Actonel (Risedronic) – US: CAFC affirms Procter & Gamble’s Actonel patent validity; nonobviousness of positional isomer: Procter & Gamble v Teva (Patent Docs) (Patently-O) (SmartBrief) (SmartBrief) (GenericsWeb) Alimta (Pemetrexed) – US: Eli Lilly and Princeton University sue… [read post]
26 Apr 2009, 7:06 am
• Drug company Eli Lilly announced that first quarter income was up 23% as a result of cost-cutting measures. [read post]
15 Jun 2011, 4:56 am
(Patent Docs) Strattera (Atomoxetine)- US: Patent infringement complaint filed in response to Para IV certification: Eli Lilly & Co. v. [read post]
8 Sep 2011, 7:07 am
Eli Lilly & Co., 589 F.3d 1336, 1351 (Fed. [read post]
23 Apr 2012, 3:33 am
Bristol and Eli Lilly and Co. make Erbitux at $100,000 per year. [read post]
24 Jul 2011, 9:44 am
Human Genome Sciences Inc v Eli Lilly and Company, heard 18 – 20 July 2011. [read post]
20 Jul 2020, 11:20 am
The patent owner (Eli Lilly & Company) sent a warning letter to the Defendant, and the latter undertook not to launch the product for which it had just obtained an MA without giving the patentee 30 days’ prior notice. [read post]
